Membrane-type 1 matrix metalloproteinase (MT1-MMP/MMP-14) has been believed a key enzyme in tumor invasion, because it is expressed in a variety of malignant human tumors, and overexpression of the enzyme enhances the ability of cellular invasiveness. However, it has not necessarily been clarified whether the endogenously expressed MT1-MMP in human tumors plays a critical role in their invasiveness. We used RNA silencing technology to downregulate the endogenous MT1-MMP expression in human tumor cells (fibrosarcoma HT1080 and gastric carcinoma MKN-28 cell lines), and evaluated the effect on the invasion of a reconstituted basement membrane (Matrigel). Transfection of a doublestranded RNA targeted to the MT1-MMP gene decreased the level of the enzyme to less than 10-20% without affecting production of other MMPs. According to the degree of silencing, activation of proMMP-2 was inhibited. CD44 shedding was also inhibited, but only in part. Decreased MT1-MMP levels were also reflected in reduced cell motility on hyaluronan (HA) and invasion in Matrigel. Thus, specific downregulation of MT1-MMP expression was sufficient to cause significant inhibition of the migration and invasion of tumor cells, even though other MMPs continued to be expressed.
Introduction
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that collectively degrade most components of the extracellular matrix (ECM) (Nagase and Woessner, 1999; Egeblad and Werb, 2002) . Recent studies have expanded on their substrates to include non-ECM molecules such as growth factors, cytokines, receptors, and cell adhesion molecules (McCawley and Matrisian, 2001a; Egeblad and Werb, 2002; Seiki, 2002) . Thus, MMPs regulate a wide array of bioactive molecules in the extracellular milieu by degradation or processing. To date, 23 MMPs have been identified in mammals. They differ in substrate specificity and the control of gene expression (Nagase and Woessner, 1999; Egeblad and Werb, 2002; Overall and Lopez-Otin, 2002 ). Tumor cells frequently overexpress multiple MMPs that are believed to play roles collectively in the invasive and metastatic growth of tumors (Stetler-Stevenson and Yu, 2001; Egeblad and Werb, 2002) .
Membrane-type MMPs (MT-MMPs), a subgroup of the MMP family composed of six members, are expressed on the surface of producer cells through a C-terminal sequence that acts either as a type I transmembrane domain or as a signal for GPI anchoring (Seiki, 2002) . As they localize on the surface of the cell, MT-MMPs are responsible for proteolysis in the pericellular space and eventually affect various cellular functions (Seiki, 2002) . MT1-MMP is of particular interest because it is expressed most frequently in human tumors (Sato et al., 1994; Seiki, 1999; Okada, 2000) . MT1-MMP degrades ECM molecules such as collagen types I, II, and III, fibronectin, laminin-1 and -5, vitronectin and aggrecan, etc. (Egeblad and Werb, 2002) . It also recruits proMMP-2 to the cell surface (Seiki, 2002) and causes its activation (Atkinson et al., 1995) by cleaving the propeptide sequence. Since MMP-2 can degrade native type IV collagen, MT1-MMP and MMP-2 assembled on the tumor cell surface forms a potent system to invade the basement membrane and interstitial stroma. The activation of MMP-2 in tumor tissues correlates well with the expression levels of MT1-MMP and local invasion by tumor cells (Okada, 2000) . MT1-MMP acts also as a processing enzyme for CD44 (Kajita et al., 2001) , the g2 chain of laminin-5 (Koshikawa et al., 2000) , the integrin av chain (Ratnikov et al., 2002) , and tissue transglutaminase (tTG) (Belkin et al., 2001) , and modulates the cell migration property as a result. Cytokine inactivation may also be caused by MT1-MMP on the cell surface . As expected from its proteolytic activity and expression in aggressive tumors, MT1-MMP, when overexpressed, strongly promotes cellular invasion in vitro (Sato et al., 1994; Hotary et al., 2000) and experimental metastasis (Tsunezuka et al., 1996) . However, it is not clear whether endogenously expressed MT1-MMP is a critical part of the cellular invasiveness in the presence of other MMPs.
In this study, we used three human tumor cell lines, fibrosarcoma HT1080, gastric carcinoma MKN-28, and TMK-1 cells, and examined the specific roles of the MT1-MMP endogenously expressed in two of these cell lines. To knockout the expression of MT1-MMP, we used RNA silencing technology, in which sequence-specific degradation of mRNA is induced by double-stranded RNA (dsRNA) (Elbashir et al., 2001) . Expression of MT1-MMP was successfully downregulated to less than 10-20% by treating the cells with the dsRNA specific to MT1-MMP. Using the cells, MT1-MMP was demonstrated to be essential for the activation of proMMP-2, migration on a HA-coated matrix, and invasion into Matrigel. Thus, our results provide a basis for the specific targeting of MT1-MMP for cancer therapy.
Materials and methods

Cell culture, transfection, and expression plasmids
The human fibrosarcoma cell line HT1080 was obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA) and cultured in Dulbecco's modified Eagle's medium (Sigma Chemical Co., Ltd., St Louis, MO, USA) with 10% fetal bovine serum (FBS), streptomycin, and penicillin. The gastric cancer cell line, MKN-28 and TMK-1 cells were obtained from RIKEN Cell Bank (Tsukuba, Japan) and cultured in RPMI 1640 medium (Sigma) with 10% FBS and kanamysin. For transfection, cells were seeded in six-well plates at 1 Â 10 5 cells/well and the expression plasmids were introduced using FuGENE6 (Roche Molecular Biochemicals, Basel, Switzerland), according to the manufacturer's instructions. Expression plasmids for TIMP-1 and TIMP-2 were reported previously .
Antibodies and inhibitors
Rabbit polyclonal antibodies (pAb) were prepared using the stem region of human CD44 and the catalytic domain of MT1-MMP. Mouse anti-actin antibody was purchased from Chemicon International (CA, USA). Peroxidase-linked antibodies (sheep anti-mouse IgG and donkey anti-rabbit IgG) were obtained from Amersham Biosciences KK (Tokyo, Japan). Mouse anti-MT1-MMP monoclonal antibodies recognizing the hemopexine-like (PEX) domain (222-1D8) were gifted from Dr Iwata (Daiichi Fine Chemical Co. Ltd, Takaoka, Japan). BB94 was a gift from Dr Peter D Brown (British Biotech Pharmaceuticals Ltd., Oxford, UK). Concanavalin A (Con A) and Phorbol 12-Myristate 13-Acetate (PMA) were from Sigma.
RT-PCR and primers
In brief, total RNA samples (3 mg) were reverse-transcribed using 0.3 mg. of random primer. Then, a portion of the cDNA product was amplified with Taq DNA polymerase using a Takara DNA thermal cycler MP (Takara Co., Kyoto, Japan) for 30 cycles (20 cycles for glyceraldehydes-3-phosphate dehydrogenase, GAPDH). The primers are as follows: MT1-MMP, primer-1 (GCTTGCAAGTAACAGGCAAA) and primer-2 (AAATTCTCCGTGTCCATCCA); MT2-MMP, primer-1 (TCGACGAAGAGACCAAGGAGT) and primer-2 (CTTGAAGTTGTCAACGTCCT); MT3-MMP, primer-1 (ATGTGCTACAGTCTGCGGAAC) and primer-2 (TATC-CACATCACGTTTGCCA); MT5-MMP, primer-1 (GGAT-CAGACAACGATCGAGT) and primer-2 (CAGCTTGAA-GTTGTGCGTCT); GAPDH, primer-1 (AAGGCTGAGAA-CGGGAAGCTTGTCATCAAT) and primer-2 (TTCCCGT-CTAGCTCAGGGATGACCTTGCCC).
RNA interference
First, 21-or 23-nucleotide dsRNAs were prepared using singlestranded complementary RNA molecules with a two-nucleotide tail (UU): MT1-MMP, AUGCAGAAGUUUUACGG-CUUGUU and CAAGCCGUAAAACUUCUGCAUUU; EGFP, GCACCAUCUUCUUCAAGGACGUU and CGU-CCUUGAAGAAGAUGGUGCUU; FLAG, ACAAGGAC-GACGAUGACAAUU and UUGUCAUCGUCGUCCUU-GUUU. For transfection, cells (1 Â 10 5 cells per well) were seeded in the six-well plates, and 30 ml of dsRNA (20 mm) was added and transfected using OLIGOFECTAMINE (Invitrogen) according to the instructions for the reagent.
Western blot analysis
SDS-containing polyacrylamide gel electrophoresis (SDS-PAGE) was carried out as described previously, and proteins separated on the gel were transferred to a PVDF membrane . Following blocking with 5% fat-free dry milk in Tris-buffered saline, the membrane was probed with primary antibodies specific to each protein. The membrane was further probed with HRP-conjugated goat anti-mouse or rabbit IgG to visualize bands.
Gelatine zymography
Gelatin zymography was performed as described elsewhere (Sato et al., 1994) . Samples were mixed with SDS sample buffer without reducing agent and separated on 7.5% acrylamide gels containing 0.1% gelatin. The gels were incubated at 371C after removing the SDS by washing the gel with 2.5% Triton X-100-containing buffer. The gels were stained with Coomassie Brilliant Blue R250, and the gelatinolytic activities were detected as clear bands against a blue background.
Migration assay
A 0.1 ml aliquot of HT1080 cell suspension at 1 Â 10 5 cells/ml was seeded on the upper chamber of transwell filters (8 mm pore). FBS (10%)-containing medium was added to the lower chamber and incubated for 14 h at 371C. Nonmigrating cells that remained on the upper surface of the filter were removed, and the remaining cells on the lower surface of the filter were fixed with 100% methanol, stained and counted under a microscopy. Each assay was carried out in triplicate.
Matrigel invasion assay
The Matrigel invasion assay was carried out according to the manufacturer's instructions (Becton Dickinson). A 0.5 ml aliquot of HT1080 cell suspension at 1 Â 10 5 cells/ml was seeded on the upper chamber of Matrigel-coated transwell filters (8 mm pore). The conditioned medium without serum was added to the lower chamber and incubated for 16 h. Noninvading cells that remained on the upper surface of the filter were removed, and the cells that appeared on the lower surface of the filter were fixed with 100% methanol, stained and counted under a microscope. Each assay was carried out in triplicate.
Indirect immunofluorescence staining
Cells cultured on coverslips were fixed with 3% paraformaldehyde in PBS containing 75 mm lysine. After blocking with 5% goat serum and 3% bovine serum albumin in TBS for 1 h at room temperature, cells were reacted with an anti-MT1-MMP pAb at room temperature for 1 h. CaCl 2 (1 mm) was included throughout the washing and incubation for the staining with the anti-MT1-MMP antibody. Cy3-conjugated donkey anti-rabbit IgG was used to visualize the antigen signal.
Results
Specific scilencing of MT1-MMP using dsRNA
We used RNA silencing technology to downregulate the expression of MT1-MMP in HT1080 cells and tried to evaluate the importance of this particular enzyme to the invasive property of the cells. Oligonucleotides corresponding to the mRNA sequence for human MT1-MMP were synthesized and dsRNAs were prepared. The dsRNAs were introduced into the cells by transfection and the levels of mRNAs for MT1-MMP and other MT-MMPs were analysed by RT-PCR (Figure 1a) . One of the dsRNAs (dsRNA/MT1) caused a specific reduction of MT1-MMP mRNA without affecting other MT-MMP mRNA levels, such as MT2, MT3, and MT5-MMP in the cells (Figure 1a) . A dsRNA for EGFP (dsRNA/EGFP) that shows no homology to MT1-MMP mRNA was used as a transfection control. The effect of the dsRNA/MT1 on the protein level was analysed by Western blotting using anti-MT1-MMP mAb (Figure 1b ). MT1-MMP was detected as two major bands corresponding to the pro-and activated forms of MT1-MMP (Sato et al., 1994; Pei and Weiss, 1996; Yana and Weiss, 2000) . The maximum reduction was observed 1 day after transfection and the level was less than 20% of the control (Figure 1c (Figure 3a ). Cells were then treated with concanavalin A, which is known to enhance the cellular ability to activate proMMP-2 (Sato et al., 1994) . The cells transfected with dsRNA/EGFP caused activation of proMMP-2 as reported, but those with dsRNA/MT1 showed greatly reduced activation and accumulation of proMMP-2 (Figure 3b ). Secretion of proMMP-9 and its activation were not affected by the dsRNA/MT1. Thus, MT1-MMP is the major activator of proMMP-2 in HT1080 cells.
Role of MT1-MMP in CD44 shedding
CD44, which is expressed in HT1080 cells, is also a possible substrate of MT1-MMP. In a previous study, we found that expression of MT1-MMP induced shedding of CD44 (CD44 H) accompanying promotion of cell migration (Kajita et al., 2001; Mori et al., 2002) . However, MT1-MMP is not the sole enzyme that can shed CD44 (Kajita et al., 2001) . Many cell lines express CD44 and shed it into the culture medium (Goebeler et al., 1996; Okamoto et al., 1999b; Okamoto et al., 2002) , but some cell lines do not necessarily express MT1-MMP at high levels. Thus, we examined the effect of the specific downregulation of MT1-MMP expression on CD44 shedding in HT1080 cells. CD44 expressed in HT1080 cells was detected as a 95 kDa major band in the cell lysate, and the shed fragments were detected as two major bands of 90-95 and 70 kDa in the medium (Figure 4) . The 90-95 kDa bands in the medium are produced by serine proteases as reported (Kajita et al., 2001 ) and also contain intact CD44 H presumably in the membrane vesicles torn-off from the cells (our unpublished data). The 70 kDa band is generated by metalloproteinases because synthetic MMP inhibitors suppress the shedding (Okamoto et al., 1999b; Kajita et al., 2001) . The level of the 70 kDa fragment was greatly decreased by treating the cells with BB94, a synthetic broad-spectrum metalloproteinase inhibitor (Figure 4) . Then, the effect of TIMP-1 and TIMP-2 on the shedding was examined. TIMP-1 inhibits all MMPs except MT-MMPs with a transmembrane domain and some ADAMs (a disintegrin and metalloproteinases), while TIMP-2 inhibits all MMPs but not ADAMs (Egeblad and Werb, 2002) . Both TIMPs showed partial inhibition of the shedding, presumably indicating that multiple metalloproteinases are responsible for the shedding in this cell line. The activity of the inhibitors can be confirmed by the inhibition of the degradation of MT1-MMP (Figure 4 , middle panel). Specific downregulation of MT1-MMP expression by dsRNA/MT1 also resulted in a partial reduction in the level of the 70 kDa fragment. Thus, MT1-MMP is responsible for the CD44 shedding in HT1080 cells, but only in part.
Effect of MT1-MMP on the cell migration and invasion
Previously, we found that processing of CD44 by MT1-MMP accompanied promotion of cell migration, presumably modulating the cell adhesion property through CD44 (Kajita et al., 2001) . Then, we analysed the role of MT1-MMP in cell migration using dsRNA/MT1. The (Figure 5a and b) , indicating that the activity of MT1-MMP on the cell surface is important for the migration. Invasion requires coordination between degradation of the ECM barrier and cell locomotion. HT1080 cell is a well-established invasive cell line in Matrigel. Thus, we evaluated the specific role of the endogenous MT1-MMP in the invasiveness. The cells transfected with dsRNA/MT1 were applied onto Matrigel, and the cells that invaded the gel were enumerated. BB94 inhibited the invasion to 20-30% of the control (Figure 5c ) as reported . The cells transfected with dsRNA/MT1 inhibited the invasion as efficiently as BB94. Thus, MT1-MMP plays a critical role in the invasive ability of HT1080 cells. Transfection of the control dsRNA did not affect the cell migration and invasion (data not shown).
Role of MT1-MMP in gastric cancer cell lines
Since suppression of MT1-MMP in HT1080 cells resulted in inhibition of invasion, we extended the analysis to gastric cancer cells. MT1-MMP is frequently expressed in gastric carcinomas (Nomura et al., 1995) and most of the cell lines (our unpublished result). We selected two invasive cell lines for the experiments: MKN-28 is a representative cell line that expresses MT1-MMP and TMK-1 that does not as a negative control (Figure 6a) . In MKN-28 cells, dsRNA/MT1 downregulated the expression of MT1-MMP without affecting that of actin. Then, we examined the effect of the silencing on the invasion. The cells transfected with dsRNAs were applied onto Matrigel and the cells that invaded were enumerated. dsRNA/MT1 reduced the invasion to 40% of the control cells in MKN-28 (Figure 6b ) and the effect was comparable to that of BB94. On the other hand, dsRNA/MT1 showed no effect on TMK-1 (Figure 6b ), although BB94 reduced The cells were suspended in DMEM and an aliquot (1 Â 10 5 cells) was applied to a Transwell chamber with a Matrigel-coated 8 mm pore membrane. After 24 h incubation at 371C, the cells that had migrated to the lower chamber were stained and counted under a microscope. Each assay was performed in triplicate and the relative number of invaded cells (the mean7SEM) to the control, 425772 for MKN28 and 541720 for TMK-1, is presented. *Po0.01 by Student's t-test MT1-MMP as a target of tumor invasion therapy J Ueda et al the invasion to 60% of the control. Thus, suppression of invasion by dsRNA/MT1 is specific to the cells expressing endogenous MT1-MMP.
Discussion
Sequence-specific gene silencing technology was successfully applied to MT1-MMP expressed in HT1080 cells, one of the representative invasive human cell lines. Transfection of the dsRNA against MT1-MMP suppressed the expression to 10-20% at the protein level. The silencing effect was strictly sequence-specific, as it had no effect on the expression of other MT-MMPs. Since these MT-MMPs expressed in HT1080 cells have an ability to activate proMMP-2 at least in vitro, it had not been clear which one is the major player in the activation. Specific silencing of MT1-MMP clearly showed its predominant role in the activation of proMMP-2 in the cells. This is consistent with the previous observations that tissue extracts from MT1-MMP-null mice exhibited decreased activation of proMMP-2, indicating that MT1-MMP is the major activator of proMMP-2 in mice (Zhou et al., 2000) , although it is still possible that proMMP-2 activation by other MT-MMPs occurs in a certain tissue and situation. CD44, which is expressed frequently and predominantly in invasive tumor cells (Gunthert et al., 1991; Naot et al., 1997; Sneath and Mangham, 1998) , is another substrate of MT1-MMP and its processing accompanies promotion of cell migration. CD44 is a major receptor for HA (Naot et al., 1997) and presumably mediates the initial attachment of cells to the HA-rich matrix by localizing at the leading edge (Okamoto et al., 1999a; Mori et al., 2002) . Since the leading edge changes the membrane structure rapidly in a dynamic manner, flexible adhesion through CD44 seems to be appropriate as the first step of cell adhesion. Then, such a loose adhesion has to be transferred to tight adhesion via integrins to generate locomotion force (Webb et al., 2002) . Thus, MT1-MMP colocalized with CD44 presumably regulate the adhesion at the leading edge through the processing (Mori et al., 2002; Seiki, 2002) . From previous studies, it is clear that MT1-MMP is not the sole enzyme to shed CD44, although none of the others have been identified. HT1080 cells also express different types of shedding enzymes as shown in Figure 4 by the experiments using metalloproteinase inhibitors. Consistent with this result, HT1080 cells treated with dsRNA/MT1 showed a partial reduction in the CD44 shedding, indicating that MT1-MMP is responsible for the shedding in part. On the other hand, BB94 inhibited the shedding almost completely.
Although CD44 shedding by MT1-MMP was partial, silencing of MT1-MMP caused a significant reduction in the cell migration. This result may indicate that CD44 shedding by MT1-MMP plays a major role in the cell migration compared to that by other processing enzymes. MT1-MMP localizes at the leading edge (Sato et al., 1997; Itoh et al., 2001; Mori et al., 2002) and probably shed CD44 there. On the other hand, we do not know where other processing enzymes localize. It is likely that effect of CD44 shedding differ depending on the site of processing on the cell surface. However, it is also plausible that, in addition to CD44, MT1-MMP has other target molecules of which processing plays a role in the cell migration. These substrates may include cell surface adhesion molecules such as tTG and integrin av as reported (Belkin et al., 2001; Ratnikov et al., 2002) or ECM protein like laminin-5 (Koshikawa et al., 2000) . CD44 shedding looks important in migration and invasion of MKN-28 cells as well, because overexpression of a mutant CD44 (CD44HM) (Kajita et al., 2001) that cannot be shed by MT1-MMP showed inhibitory effect (data not shown).
Invasion requires a concerted action of ECM degradation and cell locomotion in the matrix. Although MMPs are collectively important for the degradation of ECM, specific silencing of MT1-MMP was sufficient to inhibit the invasion of HT1080 cells in the Matrigel. This may happen when some of the substrates degraded by MT1-MMP may not be digested by other MMPs. To date, MT1-MMP has been believed to be important for tumor invasion and metastasis. However, this is the first demonstration that MT1-MMP is a potentially sufficient target to treat invasive tumors.
Although recent clinical trials of MMP inhibitors have failed to show impressive results, MMPs are still important targets for tumor therapy (Zucker et al., 2000; McCawley and Matrisian, 2001b) . To take a step forward, we have to learn why MMP inhibitors do not have a therapeutic effect in the clinic. It should be reminded that MMPs are not only important for cancer growth and invasion, but also for the host defense (Dong et al., 1997) . Thus, broad-spectrum MMP inhibitors may suppress the host defense system and diminish the therapeutic effect. Our findings raised the possibility that targeting of a single MMP, MT1-MMP, may be enough to counteract the invasive property of aggressive tumors. If inhibition of MT1-MMP does not affect the host defense system significantly, specific targeting of MT1-MMP would have a better therapeutic effect on cancer than the MMP inhibitors that suppress multiple MMPs.
Abbreviations MMP, matrix metalloproteinase; MT-MMP, membrane-type matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase.
